{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:11:17Z","timestamp":1769825477218,"version":"3.49.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1093\/europace\/eut373","type":"journal-article","created":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T21:51:16Z","timestamp":1387403476000},"page":"308-319","source":"Crossref","is-referenced-by-count":257,"title":["A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry"],"prefix":"10.1093","volume":"16","author":[{"given":"Gregory Y.H.","family":"Lip","sequence":"first","affiliation":[]},{"given":"C\u00e9cile","family":"Laroche","sequence":"additional","affiliation":[]},{"given":"Gheorghe-Andrei","family":"Dan","sequence":"additional","affiliation":[]},{"given":"Massimo","family":"Santini","sequence":"additional","affiliation":[]},{"given":"Zbigniew","family":"Kalarus","sequence":"additional","affiliation":[]},{"given":"Lars Hvilsted","family":"Rasmussen","sequence":"additional","affiliation":[]},{"given":"M\u00e1rio Martins","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Georges","family":"Mairesse","sequence":"additional","affiliation":[]},{"given":"Harry J.G.M.","family":"Crijns","sequence":"additional","affiliation":[]},{"given":"Emmanouil","family":"Simantirakis","sequence":"additional","affiliation":[]},{"given":"Dan","family":"Atar","sequence":"additional","affiliation":[]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[]},{"given":"Panos","family":"Vardas","sequence":"additional","affiliation":[]},{"given":"Luigi","family":"Tavazzi","sequence":"additional","affiliation":[]},{"given":"Aldo P.","family":"Maggioni","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2013,12,17]]},"reference":[{"key":"key\n\t\t\t\t20170522223155_EUT373C1","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","author":"Krijthe","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170522223155_EUT373C2","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation\u2014developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170522223155_EUT373C3","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on atrial fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170522223155_EUT373C4","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1093\/eurheartj\/ehl015","article-title":"Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on atrial fibrillation","volume":"27","author":"Nieuwlaat","year":"2006","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170522223155_EUT373C5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"key\n\t\t\t\t20170522223155_EUT373C6","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (has-bled) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"key\n\t\t\t\t20170522223155_EUT373C7","first-page":"794","article-title":"EUR observational research programme: atrial fibrillation general registry pilot phase","volume":"34","author":"Lip","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170522223155_EUT373C8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/europace\/eun369","article-title":"The Registry of the German Competence Network on Atrial Fibrillation: patient characteristics and initial management","volume":"11","author":"Nabauer","year":"2009","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170522223155_EUT373C9","article-title":"Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC guidelines on atrial fibrillation: primary results of the prevention of thromboemolic events\u2014European Registry in Atrial Fibrillation (prefer in AF)","author":"Kirchhof","year":"2013","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170522223155_EUT373C10","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1160\/TH11-11-0768","article-title":"Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients","volume":"107","author":"Wilke","year":"2012","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20170522223155_EUT373C11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1742-1241.2010.02618.x","article-title":"Lone atrial fibrillation: what is known and what is to come","volume":"65","author":"Potpara","year":"2011","journal-title":"Int J Clin Pract"},{"key":"key\n\t\t\t\t20170522223155_EUT373C12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/europace\/eur241","article-title":"Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options\u2014a report from the 3rd Atrial Fibrillation Competence NETwork\/European Heart Rhythm Association consensus conference","volume":"14","author":"Kirchhof","year":"2012","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170522223155_EUT373C13","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1160\/TH11-02-0070","article-title":"Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions","volume":"105","author":"Kirchhof","year":"2011","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20170522223155_EUT373C14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/jth.12140","article-title":"Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary","volume":"11","author":"Lip","year":"2013","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t20170522223155_EUT373C15","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nrcardio.2011.112","article-title":"The role of aspirin for stroke prevention in atrial fibrillation","volume":"8","author":"Lip","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"key\n\t\t\t\t20170522223155_EUT373C16","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation Cohort Study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170522223155_EUT373C17","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.amjcard.2012.08.014","article-title":"Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from affirm)","volume":"110","author":"Sullivan","year":"2012","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170522223155_EUT373C18","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/archneurol.2012.2691","article-title":"Sex, stroke, and atrial fibrillation","volume":"69","author":"Hart","year":"2012","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20170522223155_EUT373C19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522223155_EUT373C20","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/europace\/eut292","article-title":"Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association Survey","volume":"15","author":"Lip","year":"2013","journal-title":"Europace"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/16\/3\/308\/17428694\/eut373.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T06:00:29Z","timestamp":1503468029000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article-lookup\/doi\/10.1093\/europace\/eut373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,17]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,12,17]]},"published-print":{"date-parts":[[2014,3]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/eut373","relation":{},"ISSN":["1532-2092","1099-5129"],"issn-type":[{"value":"1532-2092","type":"electronic"},{"value":"1099-5129","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12,17]]}}}